$HSTM

HEALTHSTREAM INC (HSTM): Entry into a Material Definitive Agreement

HEALTHSTREAM INC (HSTM) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 PRESS RELEASE For Immediate Release: Contact: Mollie Condra, Ph.D. Head, Investor Relations & Corporate Communications HealthStream, Inc. (615) 301-3237 mollie.condra@healthstream.com HealthStream Completes $40 Million Private Placement of Its Common Stock NASHVILLE,

Original reporting
Published Sep 15, 2026, 1:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 1:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$HSTM
Neutral
high confidence
Mentioned
$HSTM
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$HSTMNeutralHigh
01

Why it matters

The $40 M raise provides liquidity for growth and possible acquisitions, but adds ~1.4 M shares to the float, increasing dilution risk.

02

Market read

Primary disclosure of a sizable equity raise; likely to move HSTM stock on the day of announcement.

03

What to watch

Potential strategic partnership with Empath could unlock additional revenue streams.

Relevance 6/10Novelty 8/10Timing: today

Background

HealthStream is a Nasdaq‑listed provider of clinical workforce solutions; the placement was led by WJRJJ Ventures, linked to Copart founder Willis Johnson.

Company-level read

Ticker impact

$HSTMNeutralHigh confidence
Context

HealthStream announced a $40 million private placement of common stock, issuing 1.36 M shares at $29.50 each.

Expected impact

Potential modest upside if proceeds are deployed effectively; near‑term downside risk from dilution.

Evidence & confidence

Large capital raise for a mid‑cap healthcare tech firm is material news; market will price in cash boost versus dilution.

Market effects

May signal confidence in healthcare technology spend, could benefit peer platforms.

Limited to US healthcare tech sector.

Low global impact.

Counterpoint

Dilution could outweigh cash benefits, leading to short‑term price pressure.

Key entities

  • HealthStream, Inc.

    Nasdaq‑listed healthcare technology platform.

  • WJRJJ Ventures, LLC

    Investment vehicle of Willis Johnson, acquiring 1.5 M shares.

Related articles

$HSTMMed

WJRJJ Ventures Discloses Investment at HealthStream with 9.6% Stake

WJRJJ Ventures disclosed a 9.6% stake in HealthStream, acquired through open-market buys and a deal at $29.50 per share. The investment includes a one-year standstill and registration rights. WJRJJ plans to hold shares for investment but may buy or sell more over time. Willis Johnson, managing member of WJRJJ, is involved in the investment.

$HSTMHigh

HEALTHSTREAM ANNOUNCES SECOND QUARTER 2026 RESULTS

HEALTHSTREAM INC (HSTM) filed an SEC Form 8-K — Results of Operations and Financial Condition. HealthStream Announces Second Quarter 2026 Results Page 1 August 3, 2026 Exhibit 99.1 Contact: Scott A. Roberts Chief Financial Officer (615) 301-3182 ir@healthstream.com Media: Mollie Condra, Ph.D. Head, Investor Relations & Communications (615) 301-3237 mollie.condra@healthstre